We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+7.55%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$17.1B
AUM Growth
-$646M
Cap. Flow
-$1.62B
Cap. Flow %
-9.46%
Top 10 Hldgs %
3.13%
Holding
5,006
New
607
Increased
1,563
Reduced
1,808
Closed
822

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$62M
2
AMZN icon
Amazon
AMZN
+$53.3M
3
CVS icon
CVS Health
CVS
+$40.3M
4
PYPL icon
PayPal
PYPL
+$34.8M
5
MCD icon
McDonald's
MCD
+$34.2M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$56.8M
2
EXE
Expand Energy Corp
EXE
+$43.4M
3
CHTR icon
Charter Communications
CHTR
+$42.4M
4
CMCSA icon
Comcast
CMCSA
+$40.3M
5
MA icon
Mastercard
MA
+$37.3M

Sector Composition

Rank Sector Weight
1 Financials 12.54%
2 Technology 11.9%
3 Consumer Discretionary 9.76%
4 Healthcare 8.91%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGX icon
4201
Argan
AGX
$8.37B
-7,629
Closed -$245K
AHRT
4202
AH Realty Trust
AHRT
$517M
-83,539
Closed -$867K
AI icon
4203
PUT
C3.ai
AI
$1.59B
-24,900
Closed -$311K
AIN icon
4204
Albany International
AIN
$1.78B
-22,612
Closed -$1.78M
AIRS icon
4205
AirSculpt Technologies
AIRS
$353M
-15,188
Closed -$98K
AKAM icon
4206
CALL
Akamai
AKAM
$15.9B
-6,800
Closed -$546K
AKR icon
4207
Acadia Realty Trust
AKR
$2.84B
-30,174
Closed -$381K
ALDX icon
4208
Aldeyra Therapeutics
ALDX
$93.5M
-116,285
Closed -$621K
ALEC icon
4209
Alector
ALEC
$199M
-35,311
Closed -$334K
ALG icon
4210
Alamo Group
ALG
$2.05B
-1,835
Closed -$224K
ALL icon
4211
PUT
Allstate
ALL
$67.5B
-3,800
Closed -$473K
ALT icon
4212
Altimmune
ALT
$599M
-170,947
Closed -$2.18M
AMCR icon
4213
Amcor
AMCR
$22.1B
-50,236
Closed -$2.69M
AMPX icon
4214
Amprius Technologies
AMPX
$1.73B
-12,397
Closed -$114K
AMRC icon
4215
Ameresco
AMRC
$1.36B
-5,030
Closed -$334K
AN icon
4216
PUT
AutoNation
AN
$6.92B
-3,600
Closed -$367K
ANIK icon
4217
Anika Therapeutics
ANIK
$287M
-10,900
Closed -$259K
ANIP icon
4218
ANI Pharmaceuticals
ANIP
$1.78B
-8,751
Closed -$281K
APD icon
4219
CALL
Air Products & Chemicals
APD
$67.6B
-8,800
Closed -$2.05M
APLS
4220
DELISTED
Apellis Pharmaceuticals
APLS
-13,951
Closed -$953K
APLT
4221
DELISTED
Applied Therapeutics
APLT
-4,038
Closed -$4K
APYX icon
4222
Apyx Medical
APYX
$171M
-12,814
Closed -$58K
ARCC icon
4223
Ares Capital
ARCC
$14.4B
-138,443
Closed -$2.34M
ARKO icon
4224
ARKO Corp
ARKO
$635M
-46,585
Closed -$437K
ARMK icon
4225
Aramark
ARMK
$14.7B
-391,476
Closed -$8.82M

Similar funds

Cubist Systematic Strategies's Q4 2022 Portfolio in Review

As of Q4 2022, Cubist Systematic Strategies held 5,006 positions worth $17.1B, down 3.6% from $17.8B the previous quarter. Its ten largest holdings account for 3.1% of the portfolio.

Cubist Systematic Strategies withdrew a net $1.62B in Q4 2022, closing 822 positions and reducing 1,808 holdings. Its most notable exit was Edison International, an estimated $25.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Cubist Systematic Strategies opened a new position in Bristol-Myers Squibb worth $30.8M.

  • Cubist Systematic Strategies's largest Q4 2022 buy was Bristol-Myers Squibb: 428,476 shares worth $30.8M.
  • Cubist Systematic Strategies added most to Apple in Q4 2022, an estimated $62M increase.
  • Cubist Systematic Strategies's biggest Q4 2022 reduction was Visa, cutting an estimated $56.8M.
  • Cubist Systematic Strategies fully exited Edison International in Q4 2022, selling an estimated $25.2M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.1% of its $17.1B portfolio in Q4 2022.
  • Cubist Systematic Strategies opened 607 new positions and closed 822 in Q4 2022.
  • Cubist Systematic Strategies's portfolio value fell 3.6% quarter-over-quarter to $17.1B.

Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.